IP Case Summaries Not Obvious to use Priority Date of First Patent or Second Patent for Obvious-Type Double Patenting Analysis July 20, 2015 Eli Lilly Canada Inc. v. Apotex Inc., 2015 FC 875 (Gleason, J.)
IP Case Summaries Refusal to List Patent Remitted to Minister of Health July 17, 2015 Eli Lilly Canada Inc. v. Canada (Attorney General). 2015 FCA 166 (Nadon J.A., Dawson J.A., Boivin J.A.)
IP Case Summaries Order Varied in Patent Infringement Case July 15, 2015 Astrazeneca Canada Inc. v. Apotex Inc., 2015 FC 671 (Barnes, J.)
IP Case Summaries Prior Art and Obviousness: No Palpable or Overriding Errors July 14, 2015 E. Mishan & Sons, Inc. v. Supertek Canada Inc., 2015 FCA 163 (Ryer J.A., Webb J.A., Near J.A.)
IP Case Summaries Appeal Held Moot Due to Withdrawal of Trade-mark Application for Registration July 07, 2015 Engineers Canada v. MMI-IPCO, LLC, 2015 FC 839 (Brown, J.)
IP Case Summaries FCA Upholds Federal Court’s Finding of Inutility July 06, 2015 Astrazeneca Canada Inc. v. Apotex Inc., 2015 FCA 158 (Dawson, J.A.)
IP Case Summaries No Reason to Depart From A Reasonably Diligent Search June 19, 2015 Teva Canada Ltd. v. Novartis, 2015 FC 770 (O'Reilly J.)
IP Case Summaries Federal Court grants $61.7M accounting of profits in pharmaceutical patent case June 18, 2015 ADIR et al v Apotex Inc et al, 2015 FC 721 (Gagné J.)
IP Case Summaries Stay of NOC Issuance Granted June 12, 2015 Horizon Pharma plc v. Canada (Health), 2015 FC 744 (Gagné J.)
IP Case Summaries Costs Principles in Modern Litigation June 11, 2015 Red Label Vacations Inc. v. 411 Travel Buys Ltd., 2015 FC 743 (Mr. Bruce Preston, Assessment Officer)